Tower Research Capital LLC (Trc) Harmony Biosciences Holdings, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,859 shares of HRMY stock, worth $134,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,859

Previous 4,110 6.11%

Holding current value

$134,216

Previous $164,000 19.51%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$31.86 - $41.49 $7,996 - $10,413	-251 Reduced 6.11%	3,859 $132,000
Q3 2024 Nov 14, 2024	SELL	$30.0 - $39.95 $250,530 - $333,622	-8,351 Reduced 67.02%	4,110 $164,000
Q2 2024 Aug 13, 2024	BUY	$28.81 - $33.01 $351,366 - $402,589	12,196 Added 4602.26%	12,461 $375,000
Q1 2024 May 15, 2024	SELL	$29.93 - $35.06 $178,741 - $209,378	-5,972 Reduced 95.75%	265 $8,000
Q4 2023 Feb 13, 2024	BUY	$19.2 - $33.78 $70,387 - $123,837	3,666 Added 142.59%	6,237 $201,000
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $61,005 - $74,664	1,913 Added 290.73%	2,571 $84,000
Q2 2023 Aug 14, 2023	SELL	$30.5 - $37.4 $143,624 - $176,116	-4,709 Reduced 87.74%	658 $23,000
Q1 2023 May 09, 2023	BUY	$30.8 - $53.92 $157,018 - $274,884	5,098 Added 1895.17%	5,367 $175,000
Q4 2022 Feb 10, 2023	SELL	$45.4 - $60.91 $75,772 - $101,658	-1,669 Reduced 86.12%	269 $14,000
Q3 2022 Nov 10, 2022	BUY	$42.06 - $55.45 $23,090 - $30,442	549 Added 39.52%	1,938 $86,000
Q2 2022 Aug 15, 2022	BUY	$33.54 - $52.15 $37,162 - $57,782	1,108 Added 394.31%	1,389 $68,000
Q1 2022 May 12, 2022	SELL	$33.14 - $51.13 $6,727 - $10,379	-203 Reduced 41.94%	281 $14,000
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $1,295 - $1,668	38 Added 8.52%	484 $21,000
Q3 2021 Nov 15, 2021	SELL	$25.68 - $38.61 $32,510 - $48,880	-1,266 Reduced 73.95%	446 $17,000
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $31,100 - $40,061	1,198 Added 233.07%	1,712 $48,000
Q1 2021 May 17, 2021	BUY	$27.56 - $40.37 $8,488 - $12,433	308 Added 149.51%	514 $17,000
Q4 2020 Feb 16, 2021	SELL	$31.74 - $51.34 $96,299 - $155,765	-3,034 Reduced 93.64%	206 $7,000
Q3 2020 Nov 16, 2020	BUY	$30.96 - $44.39 $100,310 - $143,823	3,240 New	3,240 $110,000

Others Institutions Holding HRMY

# of Institutions

255

Shares Held

46.7M

Call Options Held

119K

Put Options Held

50K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.06B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Harmony Biosciences Holdings, Inc. Transaction History